315 related articles for article (PubMed ID: 18512095)
1. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion.
Fert-Bober J; Leon H; Sawicka J; Basran RS; Devon RM; Schulz R; Sawicki G
Basic Res Cardiol; 2008 Sep; 103(5):431-43. PubMed ID: 18512095
[TBL] [Abstract][Full Text] [Related]
2. Influence of ischemia/reperfusion and modulation of PI3K/Akt kinase pathway on matrix metalloproteinase-2 in rat hearts.
Spániková A; Ivanová M; Matejíková J; Ravingerová T; Barancík M
Gen Physiol Biophys; 2010 Mar; 29(1):31-40. PubMed ID: 20371878
[TBL] [Abstract][Full Text] [Related]
3. Duration of ischaemia determines matrix metalloproteinase-2 activation in the reperfused rabbit heart.
Prasan AM; McCarron HC; White MY; McLennan SV; Tchen AS; Hambly BD; Jeremy RW
Proteomics; 2002 Sep; 2(9):1204-10. PubMed ID: 12362337
[TBL] [Abstract][Full Text] [Related]
4. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury.
Schulze CJ; Wang W; Suarez-Pinzon WL; Sawicka J; Sawicki G; Schulz R
Circulation; 2003 May; 107(19):2487-92. PubMed ID: 12707244
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation status of matrix metalloproteinase 2 in myocardial ischaemia-reperfusion injury.
Sariahmetoglu M; Skrzypiec-Spring M; Youssef N; Jacob-Ferreira AL; Sawicka J; Holmes C; Sawicki G; Schulz R
Heart; 2012 Apr; 98(8):656-62. PubMed ID: 22397940
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart.
Cheung PY; Sawicki G; Wozniak M; Wang W; Radomski MW; Schulz R
Circulation; 2000 Apr; 101(15):1833-9. PubMed ID: 10769285
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial dysfunction contributes to myocardial depression in ischemia-reperfusion in the rat.
Qi XL; Nguyen TL; Andries L; Sys SU; Rouleau JL
Can J Physiol Pharmacol; 1998 Jan; 76(1):35-45. PubMed ID: 9564547
[TBL] [Abstract][Full Text] [Related]
8. Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition.
Giricz Z; Lalu MM; Csonka C; Bencsik P; Schulz R; Ferdinandy P
J Pharmacol Exp Ther; 2006 Jan; 316(1):154-61. PubMed ID: 16166272
[TBL] [Abstract][Full Text] [Related]
9. [Precondition with doxycycline administration abates ischemia/reperfusion injury and reduces the expression of matrix metalloproteinase-1/9 in myocardium in rat in vivo].
Wu LM; Fan L; Chen LL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):679-82. PubMed ID: 17996137
[TBL] [Abstract][Full Text] [Related]
10. Effect of duration of ischemia on myocardial proteome in ischemia/reperfusion injury.
Fert-Bober J; Basran RS; Sawicka J; Sawicki G
Proteomics; 2008 Jun; 8(12):2543-55. PubMed ID: 18563752
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of endogenous nitric oxide in the heart enhances matrix metalloproteinase-2 release.
Wang W; Viappiani S; Sawicka J; Schulz R
Br J Pharmacol; 2005 May; 145(1):43-9. PubMed ID: 15711589
[TBL] [Abstract][Full Text] [Related]
12. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
[TBL] [Abstract][Full Text] [Related]
13. [Ischemic preconditioning of the myocardium: the role of changes in the permeability of the coronary microcirculation].
Di Napoli P; Di Muzio M; Contegiacomo G; Tiloca P; Spoletini L; Di Crecchio A; Gallina S; Barsotti A
Cardiologia; 1997 Jan; 42(1):59-67. PubMed ID: 9118156
[TBL] [Abstract][Full Text] [Related]
14. Role of matrix metalloproteinase-2 in the cardioprotective effect of ischaemic postconditioning.
Donato M; D'Annunzio V; Buchholz B; Miksztowicz V; Carrión CL; Valdez LB; Zaobornyj T; Schreier L; Wikinski R; Boveris A; Berg G; Gelpi RJ
Exp Physiol; 2010 Feb; 95(2):274-81. PubMed ID: 19880538
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotection.
Bellosta S; Gomaraschi M; Canavesi M; Rossoni G; Monetti M; Franceschini G; Calabresi L
FEBS Lett; 2006 Oct; 580(25):5974-8. PubMed ID: 17052715
[TBL] [Abstract][Full Text] [Related]
16. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
[TBL] [Abstract][Full Text] [Related]
17. Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity.
Deschamps AM; Yarbrough WM; Squires CE; Allen RA; McClister DM; Dowdy KB; McLean JE; Mingoia JT; Sample JA; Mukherjee R; Spinale FG
Circulation; 2005 Mar; 111(9):1166-74. PubMed ID: 15723986
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C betaII peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury.
Omiyi D; Brue RJ; Taormina P; Harvey M; Atkinson N; Young LH
J Pharmacol Exp Ther; 2005 Aug; 314(2):542-51. PubMed ID: 15878997
[TBL] [Abstract][Full Text] [Related]
19. Dendroaspis natriuretic peptide protects the post-ischemic myocardial injury.
Ha KC; Piao CS; Chae HJ; Kim HR; Chae SW
Regul Pept; 2006 Jan; 133(1-3):13-9. PubMed ID: 16289365
[TBL] [Abstract][Full Text] [Related]
20. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.
Hung YC; Chen TY; Lee EJ; Chen WL; Huang SY; Lee WT; Lee MY; Chen HY; Wu TS
J Pineal Res; 2008 Nov; 45(4):459-67. PubMed ID: 18624955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
